CRNXCrinetics Pharmaceuticals, Inc.

$34.99

Who owns CRNX

240 institutions reported holding CRNX for 2026Q1, together 118% of the company, more than the 237 a quarter earlier.

240

Institutions reporting a position · as of 2026Q1 · up from 237 the quarter before

Shares held by institutions
122.7M

Shares held by institutions · 118% of the company · long US equity positions only, as reported on Form 13F

Reported value
$4.46B

Reported value · at 2026-03-31 prices, not today's

Opened vs closed
41 / 43

Opened vs closed · new positions against positions exited in the latest quarter

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
31
New positions
41
Positions exited
43
Added to
109
Reduced
57
Institutional ownership by quarter, 2018Q3 to 2026Q1
QuarterFilersSharesReported value
2026Q1240122.7M$4.46B
2025Q4237111.6M$5.19B
2025Q3222107.6M$4.48B
2025Q2219104.5M$3.01B
2025Q1224101.9M$3.42B
2024Q424499.5M$5.09B
2024Q323284.1M$4.30B
2024Q223182.1M$3.68B
2024Q120280.3M$3.76B
2023Q418070.6M$2.51B
2023Q317168.5M$2.04B
2023Q213954.1M$974M
2023Q112755.1M$884M
2022Q412154.8M$1.00B
2022Q312251.4M$1.01B
2022Q211150.6M$945M
Largest reported holders, 2026Q1
HolderShares% of companyValue
FMR LLC15.8Mn/a$572M
VANGUARD GROUP INC10.2Mn/a$370M
BlackRock Inc.8.5Mn/a$308M
FARALLON CAPITAL MANAGEMENT LLC8.3Mn/a$303M
WELLINGTON MANAGEMENT GROUP LLP8.2Mn/a$296M
Driehaus Capital Management LLC6.4Mn/a$232M
PRICE T ROWE ASSOCIATES INC /MD/5.4Mn/a$195M
HENDERSON GROUP PLC4.5Mn/a$164M
EcoR1 Capital, LLC4.3Mn/a$156M
Bellevue Group AG3.3Mn/a$119M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…